The 14th conference SCWD will take place online on 11-12 December 2021 and gather around 500 clinicians and researchers interested in cachexia, sarcopenia and muscle wasting.
The 14th international conference on cachexia and sarcopenia to be hosted digitally on 11-12 December, 2021
With increasing uncertainties around variants of the COVID-19 virus, the SCWD Board has made the decision to cancel plans for the in-person component of 14th international conference on cachexia and sarcopenia in Ljubjana, Slovenia. As medical professionals, it is imperative that we put the health and safety of our participants first, and developments surrounding the virus and its variants have raised significant concerns about safely bringing a large group of people together.
On 11-12 December 2021, we will present highlights of 2021 from a point of view of basic science and clinical science. Online access on our secure interactive platform will be free for all SCWD members.
We remain committed to delivering the leaders in education and research regarding cachexia, sarcopenia and muscle wasting.
We are therefore glad to announce that the 15th international conference on cachexia and sarcopenia will take place in Lisbon, Portugal, on 1-3 July, 2022. It will be an excellent forum to discuss in-person the latest research and findings in cachexia, sarcopenia and muscle wasting.
While we are all disappointed not to have the opportunity to meet in-person, we remain hopeful that we will soon see the end of this pandemic and will be able to meet safely again in July 2022 in Lisbon.
Thank you for your understanding. We look forward to seeing you – safely – online in December!
The SCWD Board
This year, the 14th international SCWD Conference on Cachexia, Sarcopenia and Muscle Wasting with support of Charité University.
Recent Projects include:
• International conferences
• Consensus workshops
• The Journal of Cachexia, Sarcopenia and Muscle (JCSM)
More on the SCWD society >
Cachexia, Sarcopenia and Muscle Wasting: Definition
Dr A Schols – towards a multi-modal intervention strategy in cachexia treatment
Dr John Morley discuses recent sarcopenia definitions
Prof Muscaritoli on the Premio study and cachexia prevalence in patients with cancer